RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi
2002-01-01 Garipoli, Claudia; Adamo, Vincenzo; R., Rossello; Zanghi', Mariangela; Alafaci, Elisabetta; Altavilla, Giuseppe; Maisano, Carmelo; G., Spitaleri
Extended RAS mutation testing on wild-type KRAS exon 2 metastatic colorectal cancer.
2014-01-01 Giuffre', Giuseppe; Ieni, Antonio; Simone, Angela; Scarfi', Rosa; DE LUCA, Giuseppa; Berenato, Rosa; Adamo, Vincenzo; Tuccari, Giovanni
First-Line Treatment of Over 1000 Italian Patients Affected by Stage IIIB-IV NSCLC: Results from the Observational “Sun” (Survey on the Lung Cancer Management) Study
2009-01-01 C., Gridelli; E., Bajetta; F., De Marinis; L., Crinò; S., Barni; A., Ardizzoni; V., Gebbia; Adamo, Vincenzo; R., Morena; A., Caprioli; on behalf of SUN study, Group
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations.
2011-01-01 Franchina, Tindara; Caristi, Nicola; Proto, Claudia; Chiofalo, G; Toscano, G; Ricciardi, GIUSEPPINA ROSARIA; Colonese, F; Caccamo, Daniela; Ientile, Riccardo; Adamo, Vincenzo
From Biomolecolar and Technological Innovations to Clinical Applications.
2006-01-01 Adamo, Vincenzo; Giuseppe, Colucci; Nicola, Gebbia; Antonio, Russo; Guest, Editors
Gefitinib versus Erlotinib treatment in Non Small Cell Lung Cancer (NSCLC): comparison of two clinical experiences.
2009-01-01 Franchina, Tindara; A., Scimone; Denaro, Nerina; P., Gambadauro; G., Chiofalo; Alafaci, Elisabetta; C., Maisano; Picciotto, Maria; E., Restuccia; G., Toscano; Adamo, Vincenzo
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study
2000-01-01 Adamo, Vincenzo; A., D'Angelo; Ferraro, Giuseppa; Alafaci, Elisabetta; Altavilla, Giuseppe; Garipoli, Claudia; Magno, Carlo; A., Scimone; Zanghi', Mariangela
Gemcitabine (GEM) and liposomal doxorubicin (PLD) in recurrent/metastatic breast carcinoma: A phase II study
2005-01-01 Adamo, Vincenzo; G., Ferrandina; M., Spada; F., Ferrau; G., Condemi; L., DI LULLO; D., Lorusso; R., Rossello; Garipoli, Claudia
gemcitabine and pegylated liposomial doxorubicin in recurrent epithelial ovarian cancer (REOC).Preliminary report a phase II study
2002-01-01 Zanghi', Mariangela; Adamo, Vincenzo; F., Devincenzo; Garipoli, Claudia; Alafaci, Elisabetta; Maisano, Carmelo; A., Scimone
HER-2 overexpression in advanced node-positive gastric carcinomas: is there any relationship with other clinico-pathological histoprognostic parameters?
2010-01-01 Giuffre', Giuseppe; Ieni, Antonio; Colonese, Francesca; Barresi, Valeria; Scarfi', Rosa; Simone, Angela; G., Branca; Adamo, Vincenzo; Tuccari, Giovanni
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi | 1-gen-2002 | Garipoli, Claudia; Adamo, Vincenzo; R., Rossello; Zanghi', Mariangela; Alafaci, Elisabetta; Altavilla, Giuseppe; Maisano, Carmelo; G., Spitaleri | |
Extended RAS mutation testing on wild-type KRAS exon 2 metastatic colorectal cancer. | 1-gen-2014 | Giuffre', Giuseppe; Ieni, Antonio; Simone, Angela; Scarfi', Rosa; DE LUCA, Giuseppa; Berenato, Rosa; Adamo, Vincenzo; Tuccari, Giovanni | |
First-Line Treatment of Over 1000 Italian Patients Affected by Stage IIIB-IV NSCLC: Results from the Observational “Sun” (Survey on the Lung Cancer Management) Study | 1-gen-2009 | C., Gridelli; E., Bajetta; F., De Marinis; L., Crinò; S., Barni; A., Ardizzoni; V., Gebbia; Adamo, Vincenzo; R., Morena; A., Caprioli; on behalf of SUN study, Group | |
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations. | 1-gen-2011 | Franchina, Tindara; Caristi, Nicola; Proto, Claudia; Chiofalo, G; Toscano, G; Ricciardi, GIUSEPPINA ROSARIA; Colonese, F; Caccamo, Daniela; Ientile, Riccardo; Adamo, Vincenzo | |
From Biomolecolar and Technological Innovations to Clinical Applications. | 1-gen-2006 | Adamo, Vincenzo; Giuseppe, Colucci; Nicola, Gebbia; Antonio, Russo; Guest, Editors | |
Gefitinib versus Erlotinib treatment in Non Small Cell Lung Cancer (NSCLC): comparison of two clinical experiences. | 1-gen-2009 | Franchina, Tindara; A., Scimone; Denaro, Nerina; P., Gambadauro; G., Chiofalo; Alafaci, Elisabetta; C., Maisano; Picciotto, Maria; E., Restuccia; G., Toscano; Adamo, Vincenzo | |
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study | 1-gen-2000 | Adamo, Vincenzo; A., D'Angelo; Ferraro, Giuseppa; Alafaci, Elisabetta; Altavilla, Giuseppe; Garipoli, Claudia; Magno, Carlo; A., Scimone; Zanghi', Mariangela | |
Gemcitabine (GEM) and liposomal doxorubicin (PLD) in recurrent/metastatic breast carcinoma: A phase II study | 1-gen-2005 | Adamo, Vincenzo; G., Ferrandina; M., Spada; F., Ferrau; G., Condemi; L., DI LULLO; D., Lorusso; R., Rossello; Garipoli, Claudia | |
gemcitabine and pegylated liposomial doxorubicin in recurrent epithelial ovarian cancer (REOC).Preliminary report a phase II study | 1-gen-2002 | Zanghi', Mariangela; Adamo, Vincenzo; F., Devincenzo; Garipoli, Claudia; Alafaci, Elisabetta; Maisano, Carmelo; A., Scimone | |
HER-2 overexpression in advanced node-positive gastric carcinomas: is there any relationship with other clinico-pathological histoprognostic parameters? | 1-gen-2010 | Giuffre', Giuseppe; Ieni, Antonio; Colonese, Francesca; Barresi, Valeria; Scarfi', Rosa; Simone, Angela; G., Branca; Adamo, Vincenzo; Tuccari, Giovanni |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 14.a Contributo in Rivista 76
- 14.a Contributo in Rivista::14.a.... 76
Data di pubblicazione
- 2010 - 2017 35
- 2000 - 2009 40
- 1991 - 1999 1
Editore
- Elsevier 1
Rivista
- ANNALS OF ONCOLOGY 27
- JOURNAL OF CLINICAL ONCOLOGY 20
- TUMORI 8
- PATHOLOGICA 6
- JOURNAL OF THORACIC ONCOLOGY 3
- EUROPEAN JOURNAL OF CANCER 2
- JOURNAL OF ONCOLOGY 2
- TUMORI 2
- BMC GERIATRICS 1
- CANCER RESEARCH 1
Keyword
- Breast cancer Lymph node Meta... 1
Lingua
- eng 48
Accesso al fulltext
- no fulltext 75
- restricted 1